# Postpartum Deworming: Improving Breastfeeding and Optimizing Infant Growth

> **NCT01748929** · PHASE4 · COMPLETED · sponsor: **McGill University Health Centre/Research Institute of the McGill University Health Centre** · enrollment: 1010 (actual)

## Conditions studied

- Intestinal Diseases, Parasitic

## Interventions

- **DRUG:** Albendazole
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01748929
- **Lead sponsor:** McGill University Health Centre/Research Institute of the McGill University Health Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02-24
- **Primary completion:** 2015-02-13
- **Final completion:** 2016-09-16
- **Target enrollment:** 1010 (ACTUAL)
- **Last updated:** 2017-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01748929

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01748929, "Postpartum Deworming: Improving Breastfeeding and Optimizing Infant Growth". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01748929. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*